Clinical Trials Browser

Not yet recruiting × Urinary Bladder Neoplasms × Epirubicin × Clear all

NCT06227065 2024-01-26

POLO

Phase 2 Not yet recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms